deltatrials
Completed PHASE1 INTERVENTIONAL 4-arm NCT02236013

A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia

A Phase 1 Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia

Sponsor: Astellas Pharma Global Development, Inc.

Conditions Acute Myeloid Leukemia
Interventions Cytarabine Daunorubicin Gilteritinib Idarubicin
Updated 26 times since 2017 Last updated: Nov 1, 2024 Started: Jan 7, 2015 Primary completion: Jul 26, 2021 Completion: Jul 26, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02236013, this PHASE1 trial focuses on Acute Myeloid Leukemia and remains completed. Sponsored by Astellas Pharma Global Development, Inc., it has been updated 26 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~Jul 2017 · 3 months · monthly snapshot~Jul 2017 – ~Oct 2017 · 3 months · monthly snapshot~Oct 2017 – ~Mar 2018 · 5 months · monthly snapshot~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Feb 2019 · 6 months · monthly snapshot~Feb 2019 – ~Apr 2019 · 59 days · monthly snapshot~Apr 2019 – ~Oct 2019 · 6 months · monthly snapshot~Oct 2019 – ~Apr 2020 · 6 months · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jul 2020 · 2 months · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Nov 2020 · 2 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Apr 2021 · 59 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Sep 2022 · 12 months · monthly snapshot~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – present · 19 months · monthly snapshot

Change History

26 versions recorded

  1. Dec 2024 — Present [monthly]

    Completed PHASE1

  2. Sep 2024 — Dec 2024 [monthly]

    Completed PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  4. Sep 2022 — Jul 2024 [monthly]

    Completed PHASE1

  5. Sep 2021 — Sep 2022 [monthly]

    Completed PHASE1

    Status: Active Not Recruiting → Completed

▶ Show 21 earlier versions

  1. May 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE1

  2. Apr 2021 — May 2021 [monthly]

    Active Not Recruiting PHASE1

  3. Feb 2021 — Apr 2021 [monthly]

    Active Not Recruiting PHASE1

  4. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting PHASE1

  5. Nov 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1

  6. Sep 2020 — Nov 2020 [monthly]

    Active Not Recruiting PHASE1

  7. Aug 2020 — Sep 2020 [monthly]

    Active Not Recruiting PHASE1

  8. Jul 2020 — Aug 2020 [monthly]

    Active Not Recruiting PHASE1

  9. May 2020 — Jul 2020 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  10. Apr 2020 — May 2020 [monthly]

    Recruiting PHASE1

  11. Oct 2019 — Apr 2020 [monthly]

    Recruiting PHASE1

  12. Apr 2019 — Oct 2019 [monthly]

    Recruiting PHASE1

  13. Feb 2019 — Apr 2019 [monthly]

    Recruiting PHASE1

  14. Aug 2018 — Feb 2019 [monthly]

    Recruiting PHASE1

  15. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE1

  16. Mar 2018 — Jun 2018 [monthly]

    Recruiting PHASE1

  17. Oct 2017 — Mar 2018 [monthly]

    Recruiting PHASE1

  18. Jul 2017 — Oct 2017 [monthly]

    Recruiting PHASE1

  19. Apr 2017 — Jul 2017 [monthly]

    Recruiting PHASE1

  20. Feb 2017 — Apr 2017 [monthly]

    Recruiting PHASE1

  21. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1

    First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Astellas Pharma Global Development, Inc.
Data source: Astellas Pharma Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations